Welcome to our dedicated page for Sono Tek news (Ticker: SOTK), a resource for investors and traders seeking the latest updates and insights on Sono Tek stock.
Sono-Tek Corporation designs and manufactures precision ultrasonic coating systems that apply thin-film coatings for electronics, medical device, energy, industrial, and research applications worldwide. Company news commonly covers customer orders for medical device coating systems, including MediCoat and ExactaCoat MD platforms, as customers move from development and early production toward higher-capability manufacturing lines. Updates also address technical collaborations for advanced materials processes, quarterly financial results, backlog trends, gross margin commentary, and demand conditions across medical, alternative energy, microelectronics, and industrial markets.
Sono-Tek (Nasdaq: SOTK) announced it received a record purchase order of over $3.6 million for a single integrated ultrasonic coating production line to manufacture medical diagnostic devices. This is the largest order in its history for one production line, placed by an existing customer that previously used Sono-Tek platforms.
The new system will integrate ultrasonic coating, complementary processes, and advanced automation to support the customer’s transition from process development to high-volume manufacturing. According to Sono-Tek, the line is expected to ship during fiscal year 2028 and reinforces its strategy of larger, more complex, higher-value systems.
Sono-Tek (Nasdaq:SOTK) reported first quarter fiscal 2027 results for the period ended May 31, 2026. Net sales rose 10% to $5.66 million, driven mainly by medical markets. Gross margin expanded to 57% from 52%, lifting gross profit 21% to $3.21 million.
Operating income increased to $897,000 and net income to $741,000, or $0.05 per diluted share. Cash, equivalents, and marketable securities were $16.65 million with no debt. Backlog was $7.73 million. Sono-Tek projects first-half 2027 revenue growth and flat to modest growth for fiscal 2027.
Sono-Tek (Nasdaq:SOTK) reported fiscal 2026 net sales of $20.9 million, up 2%, with gross margin rising to 51%. Operating income grew 81% to $1.83 million and net income rose 42% to $1.81 million.
Q4 2026 sales were $5.6 million, net income $0.56 million, cash was $14.8 million with no debt, and backlog reached about $9.1 million. Medical revenue increased 54%, electronics 16%, while alternative/clean energy declined 19%. The company projects flat to modestly higher revenue in FY 2027.
Sono-Tek (NASDAQ:SOTK) will host a conference call to discuss fiscal fourth quarter and full year 2026 financial results, for the period ended February 28, 2026.
The call is scheduled for Thursday, May 28, 2026 at 10:30 am ET, with dial-in, webcast, and replay options available to investors.
Diamond Quanta and Sono-Tek (Nasdaq: SOTK) announced a strategic collaboration on March 17, 2026 to integrate Sono-Tek precision coating systems as a standardized process module within Diamond Quanta’s engineered diamond-on-glass manufacturing architecture.
The partnership aims to improve thin-film uniformity, repeatable multilayer deposition, and structured progression from development to OEM qualification across optics, thermal, semiconductor, and quantum applications.
Sono-Tek (Nasdaq: SOTK) announced a technical collaboration with Diamond Quanta to integrate Sono-Tek’s precision ultrasonic coating systems into Diamond Quanta’s engineered diamond manufacturing workflows. The effort targets repeatable thin-film deposition, improved film uniformity, and progression toward OEM qualification and scalable manufacturing.
The collaboration emphasizes standardized process architecture to align engineered diamond-on-glass materials with semiconductor and electronics toolchains, supporting multilayer integration and manufacturability as Diamond Quanta advances toward qualification.
Sono-Tek (Nasdaq: SOTK) received a purchase order for $820,000 of ultrasonic coating equipment to be used in production of diagnostic medical devices. The order, placed through a subcontractor, scales an existing customer from earlier systems and is expected to ship in fiscal 2027.
The system deposits an electronically active layer, represents higher throughput and average selling price versus prior units, and comes from a different customer than earlier $5.0M and $2.8M medical device orders.
Sono-Tek (Nasdaq: SOTK) reported third-quarter and nine-month fiscal 2026 results for the period ended Nov. 30, 2025. Q3 net sales were $5.0M (seventh consecutive quarter >$5M) and nine-month sales were $15.3M (essentially flat YoY). Q3 gross margin expanded to 50% (QTD) and nine-month gross margin was 51%. Q3 net income rose 24% to $340k and nine-month net income rose 32% to $1.25M. Cash and marketable securities totaled $11.7M with no debt. Backlog reached a record $12.26M (up 16% YoY). The company reiterated FY2026 guidance, forecasting modest revenue growth.
Sono-Tek (NASDAQ: SOTK) reported second quarter and first half fiscal 2026 results for the period ended August 31, 2025, highlighting record first-half revenue of $10.30M and six consecutive quarters with >$5M quarterly sales. H1 net income rose 35% to $909K and Q2 net income increased 24% to $424K. Gross margin expanded to 51% (H1) and 50% (Q2), aided by favorable product mix and warranty expense. Cash, cash equivalents and marketable securities totaled $10.6M with no debt. Total equipment and service backlog was $11.21M, up 50% sequentially, driven by strong medical-market orders including ~$5M and ~$2.8M medical orders cited. Company updated FY26 guidance to modest revenue growth while noting tariff and clean-energy policy headwinds offset by medical demand.
Sono-Tek (Nasdaq: SOTK) received a purchase order valued at over $2.8 million from a major U.S. medical device manufacturer for multiple advanced ExactaCoat MD systems. The order comes from an existing customer that is ramping up production and adds higher-capability systems alongside equipment already in use. Deliveries are expected to begin in early calendar 2026 and complete within the first half of 2026. The company noted this award is from a different customer than a $5 million medical device order announced last month, which broadens its base of multi-million-dollar opportunities.
This reinforces Sono-Tek’s position in medical device coatings and supports its strategy of scaling production of higher-value systems.